SEC-sourced researchBeta
MEDS
DataMeds AI, Inc.
Company comparison ↗
Data passport
- CIK
- 0002030763
- Exchange
- Nasdaq
- Business activity
- — · SIC 5122
- Financial inputs
- 6/6
- Filing date
- Sep 17, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 18,128,831.0000 | Mar 20, 2026 |
| December 2025 | 23,337,860.0000 | Mar 20, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 23,337,860.0000 | -101,274,530.0000 | -10,855,029.0000 | 30,459,449.0000 | 42,907,250.0000 | Mar 20, 2026 |
| December 2024 | 18,128,831.0000 | -6,856,226.0000 | -1,224,993.0000 | 57,332,650.0000 | 50,598,204.0000 | Mar 20, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $23.34M | December 2025 | Mar 20, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $18.13M | December 2024 | Mar 20, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$101.27M | December 2025 | Mar 20, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$10.86M | December 2025 | Mar 20, 2026 | 10-K |
| Total assetsAssets | $30.46M | December 2025 | Mar 20, 2026 | 10-K |
| Total liabilitiesLiabilities | $42.91M | December 2025 | Mar 20, 2026 | 10-K |